dihexa metabolic stability compared to angiotensin iv Comparative bleeding risk between II receptor blockers with high versus low P-glycoprotein inhibitory activity in patients with atrial fibrillation receiving direct oral anticoagulants Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases ScienceDirect Dihexa is concentrated in multiple brain regions. Rats fitted with a Download Scientific Diagram Small Molecule AngIV based Analogs to Treat Alzheimers Disease Dihexa: Mechanism, Effects & Research Studies Angiotensin Converting Enzyme Inhibitors and Metabolic Aging: A Drosophila Perspective
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




